Tweeting Looks like SBM is back to retweeting and responding to articles, etc. on Twitter.
They reTweeted a couple articles about SGLT2 compounds being used for heart and cardiovascular issues. Wonder if that is their subtle way of telling shareholders that is what they have been expanding their SGLT2 use to as well.
Good to have another use but damn I would just like them to finalize a contract or anything at this point before flying off in another direction. They are like cats toying with a mouse - playing with it....batting it around but never quite executing it. Then off to the next spot the laser shines on. Just FINISH something - it shouldn't be this painful or difficult! Get the hell out of your own ways.